Vantage Consulting Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Vantage Consulting Group's LLY Position: Q3 2024 in Review
Vantage Consulting Group sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 268 shares — an estimated $243K sold.
Vantage Consulting Group first reported a position in LLY in Q4 2020 and held it in 14 quarters. The position peaked at $294K in Q4 2021. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.
- Vantage Consulting Group reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
- Vantage Consulting Group sold 268 Eli Lilly shares in Q3 2024, an estimated $243K.
- Vantage Consulting Group first reported a position in Eli Lilly in Q4 2020 and held it in 14 quarters.
- Vantage Consulting Group's Eli Lilly position peaked at $294K in Q4 2021.
- 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.
Based on Vantage Consulting Group's 13F filing for Q3 2024, filed 14 Nov 2024.